Abcam Plc (Abcam) is a manufacturer and supplier of life science research tools such as antibodies and associated products that enable analysis of living cells at molecular level. It develops, manufactures and markets antibodies; research-grade antibodies; in vitro diagnostic (IVD) antibodies; kits; agonists, antagonists, activators, and inhibitors; and proteins and peptides.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

The company’s focused research and development (R&D) efforts facilitate the development of new antibody products and improve the quality of its existing catalogue. It also aims at discovery research, diagnostics and therapeutic development. The company is focused on high quality, validated products and supporting scientists. Its product portfolio includes proteins, antibodies, assay kits and engineered cell lines. The company is partnering with disease charities, life science organisations, pharmaceutical and biotechnology companies. Abcam spent GB23.2 million on its R&D activities, which as a percentage of revenue stood at 6.4% in FY2022.